Neuronetics. has been granted a patent for a system that generates a fitted head model to assist in transcranial magnetic stimulation (TMS) procedures. The system utilizes a sensor to identify anatomical landmarks, enabling treatment location determination without the need for MRI, x-ray, or CT imaging. GlobalData’s report on Neuronetics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Neuronetics Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to GlobalData’s company profile on Neuronetics, Neuromodulation devices was a key innovation area identified from patents. Neuronetics's grant share as of July 2024 was 64%. Grant share is based on the ratio of number of grants to total number of patents.

System for transcranial magnetic stimulation using fitted head model

Source: United States Patent and Trademark Office (USPTO). Credit: Neuronetics Inc

The granted patent US12020804B2 describes a novel system and method for conducting transcranial magnetic stimulation (TMS) procedures. Central to this innovation is a sensor and a processor that work together to identify anatomical landmarks on a human subject's head, such as the nasion, inion, and lateral canthus, without the need for traditional imaging techniques like MRI, X-ray, or CT scans. The processor is designed to determine a motor threshold or treatment location based on these landmarks, facilitating the TMS procedure. Additionally, the system can capture images of the subject's head to enhance the accuracy of landmark identification and treatment location determination.

The patent further outlines features that improve the safety and effectiveness of TMS procedures. The processor can monitor the position of the treatment coil during the procedure, ensuring it remains within a predefined range relative to the subject's head. If the coil's position deviates from this range, the system can automatically alter or halt the TMS procedure. The system's ability to generate a head model using feedback from the sensor, without relying on conventional imaging methods, represents a significant advancement in the field of TMS, potentially making the procedure more accessible and efficient for treating neuropsychiatric disorders.

To know more about GlobalData’s detailed insights on Neuronetics, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.